STOCK TITAN

LyondellBasell (LYB) Form 144: 20,000 RSU shares for sale (~$1.07M)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LyondellBasell (LYB) insider plans to sell 20,000 shares through J.P. Morgan Securities on or about 08/15/2025, with an aggregate market value of $1,066,200 based on the filing. The shares were acquired through RSU vesting: 12,906 shares vested on 05/23/2023 and 7,094 shares vested on 02/22/2025; payment for those RSUs was recorded as compensation. The filing reports no other sales by the person in the past three months. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Positive

  • Sale is small relative to outstanding shares (~0.0062%), limiting potential market impact
  • All shares were acquired via RSU vesting and paid as compensation, indicating this is a liquidity action for vested compensation
  • Execution through a major broker (J.P. Morgan Securities LLC) provides an orderly market channel for the sale

Negative

  • None.

Insights

TL;DR: Routine insider sale of vested RSUs totaling 20,000 shares (~$1.07M) executed through a major broker; small relative to outstanding shares.

The filing documents a proposed sale of 20,000 common shares via J.P. Morgan Securities with an aggregate market value of $1,066,200. All shares were acquired through RSU vesting events and paid as compensation, indicating this is a liquidity action for compensation-related shares rather than a market purchase or financing. The sale size represents approximately 0.0062% of the issuer's reported outstanding shares (20,000 of 321,648,429), so the direct market impact is likely negligible. The filer reports no sales in the prior three months and provides the standard attestation regarding material undisclosed information.

TL;DR: Disclosure is a standard Form 144 insider notice tied to vested RSUs; documentation and broker route are routine and compliant in form.

The notice lists the acquisition dates and nature (RSU vesting) for all shares to be sold and identifies the executing broker (J.P. Morgan Securities LLC). The form includes the seller's attestation that no undisclosed material adverse information is known, which is customary. There are no reported sales in the prior three months, and the payment/source for the securities is recorded as compensation. From a governance perspective, this filing appears to be a routine compliance disclosure rather than a corporate governance event.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the LYB Form 144 report?

The filing reports a proposed sale of 20,000 common shares of LyondellBasell (LYB) through J.P. Morgan Securities LLC with an aggregate market value of $1,066,200 and an approximate sale date of 08/15/2025.

How were the LYB shares being sold acquired?

All 20,000 shares were acquired by the seller through RSU vesting: 12,906 shares on 05/23/2023 and 7,094 shares on 02/22/2025; the consideration is listed as compensation.

Has the filer sold LYB shares in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months, indicating no reported sales in that period.

What fraction of LYB's outstanding shares does this sale represent?

The sale of 20,000 shares is about 0.0062% of the reported 321,648,429 shares outstanding noted in the filing.

Does the filing indicate any undisclosed material information about LYB?

By signing the notice, the person represents they do not know any material adverse information
Lyondellbasell Industries N V

NYSE:LYB

View LYB Stock Overview

LYB Rankings

LYB Latest News

LYB Latest SEC Filings

LYB Stock Data

23.03B
256.69M
Specialty Chemicals
Industrial Organic Chemicals
Link
United Kingdom
HOUSTON